Company profile
Nunabio Limited
Home - NunaBio
Synthetic DNA production for cutting-edge biotechnology solutions.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzUyNzM0MDMxNGFkaXF6a2N4
Published 19 Jun 2026 14:16
Resolution
ResolutionRESOLUTIONS | Transaction WUYxSzFHMTVhZGlxemtjeA | Paper/PDF filed
Published 23 May 2026 22:43
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0MDMyMjQ0OWFkaXF6a2N4
Published 21 Oct 2024 03:22
Appoint Corporate Director Company With Name Date
OfficersAP02 | Transaction MzQ0MDMyMjQ1MWFkaXF6a2N4
Published 21 Oct 2024 03:22
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzODMyMzgzMWFkaXF6a2N4
Published 03 Oct 2024 03:52
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzNzUxODIyOWFkaXF6a2N4
Published 27 Sep 2024 12:06
Resolution
ResolutionRESOLUTIONS | Transaction WURCMTlLMEJhZGlxemtjeA | Paper/PDF filed
Published 10 Sep 2024 06:22
Resolution
ResolutionRESOLUTIONS | Transaction WURCMTlLU0JhZGlxemtjeA | Paper/PDF filed
Published 10 Sep 2024 06:15
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzMzY0NTQyMGFkaXF6a2N4
Published 28 Aug 2024 13:36
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Scalable economic DNA synthesis by oligoseed amplification with novel DNA polymerase enzymes
1 Sep 2023 to 28 Feb 2025
Engineered DNA is an enabler for the UK's economic success (UK-Innovation-Strategy-2021). It is a mainstream component for cell and gene therapies, advanced diagnostics, and RNA vaccines. Hundreds of kilograms of DNA will soon be required globally each year, much more than current global capacity to supply it. The long-standing mainstream DNA production m...
Automated surface-bound oligoseed DNA amplification enabling advanced therapies and diagnostics
1 Apr 2023 to 31 Mar 2025
Synthetic DNA is a mainstream component for wide-ranging established and emerging industries including cell and gene therapies and molecular diagnostics. The global DNA synthesis market is forecast to reach £3.4bn by 2025, with demand reaching hundreds of kilograms in coming years and vastly outstripping supply. Solid phase phosphoramidite chemistry, the ...
Nunabio: Providing DNA Solutions
1 Apr 2021 to 30 Sep 2022
Biological matter can be precisely identified by the base sequence of its DNA. DNA detection is therefore of global interest where biological contamination is harmful to human health -- water that contains microbial infections, air samples that convey disease, water or food that is contaminated, weapons that disperse biological agents or genetic mutations...